Cahaba Wealth Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$44.3K	Hold	21,000	–	–	﹤0.01%	154
2025 Q1	$25.6K	Buy	21,000 +4,000	+24%	+$4.88K	﹤0.01%	146
2024 Q4	$21.9K	Buy	+17,000	New	+$21.9K	﹤0.01%	145